Rachel Aronow
Family · Sarasota, FLNPI 1710548896
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 97 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 32 manufacturers reported payments, led by AbbVie at 26.8% of the total. Reporting peaked in 2023 at $1,239 and has fallen 76.3% since, to $293 in 2025. Among family clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 97 payments — averaging $36.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$959
- Biogen$327
- Lundbeck LLC$327
- Biohaven Pharmaceutical Holding Company Ltd.$182
- Biohaven Pharmaceuticals, Inc.$171
- EMD Serono, Inc.$146
- plus $1K from 26 others
What the payments were for
- Food & beverage$3,580100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 22 | $959 |
| Biogen | 5 | $327 |
| Lundbeck LLC | 11 | $327 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $182 |
| Biohaven Pharmaceuticals, Inc. | 2 | $171 |
| EMD Serono, Inc. | 1 | $146 |
| Eisai Inc. | 2 | $142 |
| Corium, LLC | 6 | $139 |
| Insightec,inc | 1 | $137 |
| Sumitomo Pharma America, Inc. | 4 | $125 |
| Abbott | 1 | $101 |
| Otsuka America Pharmaceutical, Inc. | 4 | $79 |
| Novartis | 4 | $79 |
| Neurocrine Biosciences, Inc. | 3 | $78 |
| Johnson & Johnson | 3 | $56 |
| Teva Pharmaceuticals USA, Inc. | 2 | $50 |
| GE HealthCare | 2 | $49 |
| UCB, Inc. | 2 | $44 |
| Amgen | 2 | $42 |
| Lilly USA, LLC | 2 | $41 |
| SK Life Science, Inc. | 2 | $40 |
| Pfizer | 2 | $40 |
| AstraZeneca | 1 | $35 |
| Averitas Pharma Inc. | 1 | $31 |
| Acorda Therapeutics, Inc | 1 | $29 |
| Kyowa Kirin, Inc. | 1 | $23 |
| Neurelis, Inc. | 1 | $21 |
| Nevro Corp. | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Boston Scientific | 1 | $17 |
| Cala Health, Inc. | 1 | $15 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,580 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Other family in Sarasota
- Marie ZambelliSarasota$65K
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.